Oral 9 A Placebo-Controlled Trial of Pregabalin for Irritable Bowel Syndrome

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    *EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 17, 2016 at 8:00 am EDT.


    Dr. Yuri Saito

    Yuri A. Saito, MD, MPH

    Oral 9 A Placebo-Controlled Trial of Pregabalin for Irritable Bowel Syndrome

    Author Insight from Yuri A. Saito, MD, MPH, Mayo Clinic

    What’s new here and important for clinicians?

    Treating and managing refractory abdominal pain can be challenging, as many patients do not respond to conventional treatments. Pregabalin has been used for neuropathic pain and fibromyalgia, but its effects on irritable bowel syndrome (IBS) symptoms were not known previously. This pilot study suggests that Pregabalin may be helpful for IBS-related pain and diarrhea.

    What do patients need to know?

    Pregabalin may be helpful for their IBS symptoms, especially abdominal pain and diarrhea.

    Read the Abstract

    Author Contact

    Yuri A. Saito, MD, MPH, Mayo Clinic
    saito.yuri@mayo.edu


    Media Interview Requests:

    To arrange an interview with any ACG experts or abstract authors, please contact Brian Davis of ACG via email at mediaonly@gi.org or by phone at 301-263-9000.

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks